Gilead Sciences reports positive data from HIV therapy trial

cafead

Administrator
Staff member
  • cafead   Feb 23, 2023 at 10:22: AM
via Gilead Sciences has reported positive data from the Phase Ib clinical trial of lenacapavir, along with broadly neutralising antibodies (bNAbs) teropavimab and zinlirvimab, to treat HIV.

article source